Skip to Content

Paul Duprex, Ph.D.

  • Director of the Center for Vaccine Research at the University of Pittsburgh
  • Director of the Regional Biocontainment Laboratory at Pitt
  • Jonas Salk Chair in Vaccine Research at Pitt’s School of Medicine
  • Professor of microbiology and molecular genetics at Pitt’s School of Medicine

Dr. Duprex is an expert in measles and mumps viruses and studies viral spillover from animals to humans, including the SARS-CoV-2 virus that caused the COVID-19 pandemic. He has directed the Center for Vaccine Research (CVR) at the University of Pittsburgh since 2018.

Dr. Duprex also serves as the director of the Regional Biocontainment Laboratory, a high-security facility embedded in the CVR that allows scientists to safely contain and examine potentially dangerous pathogens. He has served as the editor-in-chief of the Journal of General Virology since 2020.

Prior to working in Pittsburgh, Dr. Duprex was at Boston University School of Medicine as the director of National Emerging Infectious Diseases Laboratories (NEIDL) Imaging. He also taught as a professor in microbiology and pathology and laboratory medicine at Boston University.

Dr. Duprex also worked as a senior lecturer at Queen’s University in Belfast and served as the principal scientist and head of department at TransForm Pharmaceuticals, Johnson & Johnson.

Dr. Duprex earned his Ph.D. in molecular biology from Queen’s University Belfast in 1994.